Abstract
Localized magnetic resonance spectroscopy (LMRS) promises a powerful non-invasive means to determine myocardial triacylglycerol (TAG) in a clinical setting. Here, the linearity, specificity, robustness, precision, and accuracy of an ex vivo mouse-heart LMRS TAG assay are assessed by quantifying the spatial, spectral, and relaxation-induced uncertainties. The protocol, which is based on localization by adiabatic selective refocusing (LASER) using frequency offset corrected inversion (FOCI) pulses, alternating gradient polarity, and simple post-processing, is shown to have good characteristics. The presented protocol has a benchmark, phantom-based, accuracy of 3%, and when applied to ex vivo mouse hearts the accuracy is 6%, making the LMRS assay comparable to the typical destructive bioanalytical assay.
| Original language | English |
|---|---|
| Pages (from-to) | 382-389 |
| Number of pages | 8 |
| Journal | Journal of Pharmaceutical and Biomedical Analysis |
| Volume | 45 |
| Issue number | 3 |
| DOIs | |
| State | Published - Nov 5 2007 |
Keywords
- FOCI
- LASER
- Myocardial TAG
- Quantitative localized MRS
- T relaxation
- Triacylglycerol
Fingerprint
Dive into the research topics of 'Limits of a localized magnetic resonance spectroscopy assay for ex vivo myocardial triacylglycerol'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver